EHU134361
MISSION® esiRNA
targeting human FYCO1
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCCAGCTCCAGAGAATCATCCGAGACTTGCAAGATGCTGTGACAGAACTAAGCAAAGAATTTCAGGAAGCAGGGGAACCCATCACGGATGACAGCACCAGCTTGCATAAATTTTCTTATAAACTTGAGTATCTCCTGCAATTTGATCAGAAAGAGAAGGCCACCCTCCTGGGCAACAAGAAGGACTACTGGGATTACTTCTGTGCCTGCCTGGCCAAGGTGAAAGGAGCCAATGATGGGATCCGCTTTGTCAAGTCTATCTCAGAGCTCCGAACATCCTTGGGGAAAGGAAGAGCATTTATTCGCTACTCCTTGGTGCACCAGAGGTTGGCAGACACCTTACAGCAGTGCTTCATGAACACCAAAGTGACCAGTGACTGGTACTATGCAAGAAGCCCCTTTCT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... FYCO1(79443), FYCO1(79443)
関連するカテゴリー
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
保管分類
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Theodora Saridaki et al.
Journal of neurochemistry, 146(4), 474-492 (2018-05-11)
Parkinson's disease can be caused by mutations in the α-synuclein gene and is characterized by aggregates of α-synuclein protein. We have previously shown that over-expression of the small GTPase Rab7 can induce clearance of α-synuclein aggregates. In this study, we
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）